Hereditary hypertriglyceridemic rat: a suitable model of cardiovascular disease and metabolic syndrome?

. 2006 ; 55 Suppl 1 () : S49-S63.

Jazyk angličtina Země Česko Médium print

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid17177626

Hypertriglyceridemia and hypertension seem to be very important cardiovascular risk factors. The Prague hereditary hypertriglyceridemic (hHTG) rat was developed as a model of human hypertriglyceridemia. It was demonstrated that these rats are not obese, they are hypertensive and insulin resistant and they have some disturbances in glucose metabolism. Several QTLs were identified for blood pressure, its particular components (dependent on major vasoactive systems) and plasma triglycerides throughout the genome of hHTG rats by using of F(2) hybrids strategy. It is evident that hHTG rats are a suitable model for the study of metabolic disturbances in relation to blood pressure as well as for the search of genetic determinants of these abnormalities. Numerous abnormalities of blood pressure regulation as well as alterations in the structure and function of cardiovascular apparatus (heart, conduit and resistance arteries) were found in hHTG rats. A special attention was paid to possible changes in the efficiency of various vasoactive systems such as nitric oxide, renin-angiotensin-aldosterone system and sympathetic nervous system, which seem to contribute substantially to cardiovascular and/or metabolic abnormalities observed in Prague hereditary hypertriglyceridemic rats.

Citace poskytuje Crossref.org

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Beneficial Effect of Fenofibrate in Combination with Silymarin on Parameters of Hereditary Hypertriglyceridemia-Induced Disorders in an Animal Model of Metabolic Syndrome

. 2025 Jan 16 ; 13 (1) : . [epub] 20250116

Assessment of the Cardiovascular Risk of High-Fat-High-Fructose Diet in Hereditary Hypertriacylglycerolemic Rats and Venlafaxine Effect

. 2024 Dec 31 ; 73 (6) : 973-984.

Visceral Adipose Tissue Inflammation and Vascular Complications in a Rat Model with Severe Dyslipidemia: Sex Differences and PAI-1 Tissue Involvement

. 2024 Dec 27 ; 15 (1) : . [epub] 20241227

Female prediabetic rats are protected from vascular dysfunction: the role of nitroso and sulfide signaling

. 2024 Nov 26 ; 57 (1) : 91. [epub] 20241126

Research on Experimental Hypertension in Prague (1966-2009)

. 2024 Aug 31 ; 73 (Suppl 1) : S49-S66. [epub] 20240717

Empagliflozin alters lipid metabolism in the myocardium and liver in a prediabetes model with severe dyslipidemia

. 2024 ; 15 () : 1393946. [epub] 20240704

The Effect of Ovariectomy and Estradiol Substitution on the Metabolic Parameters and Transcriptomic Profile of Adipose Tissue in a Prediabetic Model

. 2024 May 21 ; 13 (6) : . [epub] 20240521

Hypertension after the Menopause: What Can We Learn from Experimental Studies?

. 2023 Jul 31 ; 72 (Suppl 2) : S91-S112.

Metabolic Syndrome in Hypertriglyceridemic Rats: Effects of Antioxidants

. 2023 Jun 09 ; 72 (S1) : S31-S35.

Hypolipidemic and insulin sensitizing effects of salsalate beyond suppressing inflammation in a prediabetic rat model

. 2023 ; 14 () : 1117683. [epub] 20230403

Hypolipidemic Effects of Beetroot Juice in SHR-CRP and HHTg Rat Models of Metabolic Syndrome: Analysis of Hepatic Proteome

. 2023 Jan 28 ; 13 (2) : . [epub] 20230128

The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model

. 2022 ; 2022 () : 4587907. [epub] 20220913

Beneficial Effect of Fenofibrate and Silymarin on Hepatic Steatosis and Gene Expression of Lipogenic and Cytochrome P450 Enzymes in Non-Obese Hereditary Hypertriglyceridemic Rats

. 2022 Apr 26 ; 44 (5) : 1889-1900. [epub] 20220426

Physiological reconstruction of blood glucose level using CGMS-signals only

. 2022 Apr 06 ; 12 (1) : 5796. [epub] 20220406

Synthetic Pyridoindole and Rutin Affect Upregulation of Endothelial Nitric Oxide Synthase and Heart Function in Rats Fed a High-Fat-Fructose Diet

. 2021 Dec 30 ; 70 (6) : 851-863. [epub] 20211030

The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model

. 2021 Dec 27 ; 14 (1) : . [epub] 20211227

In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia

. 2021 Oct 26 ; 22 (21) : . [epub] 20211026

Complex Positive Effects of SGLT-2 Inhibitor Empagliflozin in the Liver, Kidney and Adipose Tissue of Hereditary Hypertriglyceridemic Rats: Possible Contribution of Attenuation of Cell Senescence and Oxidative Stress

. 2021 Sep 30 ; 22 (19) : . [epub] 20210930

Metformin Affects Cardiac Arachidonic Acid Metabolism and Cardiac Lipid Metabolite Storage in a Prediabetic Rat Model

. 2021 Jul 19 ; 22 (14) : . [epub] 20210719

The combination of atorvastatin with silymarin enhances hypolipidemic, antioxidant and anti-inflammatory effects in a rat model of metabolic syndrome

. 2021 Mar 17 ; 70 (1) : 33-43. [epub] 20210114

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace